Keywords: Alzheimer's disease (AD); NF-kB (p50/p65); anti-NF-kB therapy; lipopolysaccharide; miRNA-9/miRNA-30b/miRNA-34a/miRNA-146a/miRNA-155; miRNA-based therapy; microRNA; reactive oxygen species (ROS).